Advansix Announces Third Quarter 2022 Financial Results
AdvanSix (ASIX) reported third quarter 2022 sales of $479 million, a 7% increase year-over-year, attributed to favorable market pricing and acquisitions, despite an 18% decline in sales volume due to an extended plant turnaround. Net income fell to $10 million from $44 million the previous year, leading to a decrease in diluted EPS to $0.35. Adjusted EBITDA also declined to $33.3 million. The company returned $17 million to shareholders through dividends and repurchases, with a quarterly dividend increase of 16%. Outlook for Q4 anticipates improved performance and strong cash flow generation.
- Sales increased 7% year-over-year to $479 million.
- Returned $17 million to shareholders through dividends and repurchases.
- Quarterly dividend raised by 16% to $0.145 per share.
- Net income decreased by $33.9 million year-over-year to $10 million.
- Adjusted EBITDA dropped by $44.4 million to $33.3 million.
- Cash flow from operations declined by $17.6 million to $58.9 million.
- Sales volume fell 18%, primarily due to an extended plant turnaround.
Sales of
Earnings Per Share of
Cash Flow from Operations of
Returned
Third Quarter 2022 Summary
-
Sales up approximately
7% versus prior year driven by18% favorable impact of market-based pricing,4% higher raw material pass-through pricing, and3% contribution from acquisitions, partially offset by18% lower volume -
Net Income of
, a decrease of$10.0 million versus the prior year$33.9 million -
Adjusted EBITDA of
, a decrease of$33.3 million versus the prior year$44.4 million -
Cash Flow from Operations of
, a decrease of$58.9 million versus the prior year$17.6 million -
Capital Expenditures of
, an increase of$22.2 million versus the prior year$9.2 million -
Free Cash Flow of
, a decrease of$36.7 million versus the prior year$26.8 million -
Repurchased 362,609 shares for approximately
in 3Q22; Year-to-date repurchases of approximately$13 million $24 million -
Increased 3Q22 quarterly dividend by
16% to per share$0.14 5
“Our third quarter performance reflects the resilience of our business model and our ability to navigate challenging conditions," said
Summary third quarter 2022 financial results for the Company are included below:
($ in Thousands, Except Earnings Per Share) |
3Q 2022 |
|
3Q 2021 |
||||
Sales |
$ |
478,769 |
|
|
$ |
446,495 |
|
Net Income |
|
10,032 |
|
|
|
43,942 |
|
Diluted Earnings Per Share |
$ |
0.35 |
|
|
$ |
1.51 |
|
Adjusted Diluted Earnings Per Share (1) |
$ |
0.43 |
|
|
$ |
1.58 |
|
Adjusted EBITDA (1) |
|
33,313 |
|
|
|
77,687 |
|
Adjusted EBITDA Margin % (1) |
|
7.0 |
% |
|
|
17.4 |
% |
Cash Flow from Operations |
|
58,934 |
|
|
|
76,488 |
|
Free Cash Flow (1)(2) |
|
36,703 |
|
|
|
63,495 |
|
(1) See “Non-GAAP Measures” included in this press release for non-GAAP reconciliations
(2) Net cash provided by operating activities less capital expenditures
Sales of
Sales by product line and approximate percentage of total sales are included below:
($ in Thousands) |
|
3Q 2022 |
|
|
3Q 2021 |
||||||
|
Sales |
|
% of Total |
|
Sales |
|
% of Total |
||||
Nylon |
$ |
141,017 |
|
29 |
% |
|
$ |
122,110 |
|
27 |
% |
Caprolactam |
|
90,818 |
|
19 |
% |
|
|
80,265 |
|
18 |
% |
Chemical Intermediates |
|
115,268 |
|
24 |
% |
|
|
130,920 |
|
29 |
% |
Ammonium Sulfate |
|
131,666 |
|
28 |
% |
|
|
113,200 |
|
26 |
% |
|
$ |
478,769 |
|
100 |
% |
|
$ |
446,495 |
|
100 |
% |
Adjusted EBITDA of
Adjusted earnings per share of
Cash flow from operations of
Dividend
The Company's Board of Directors declared a quarterly cash dividend of
Outlook
- 4Q22 expected performance rebounding towards results demonstrated in 1Q22 and 2Q22 as well as continued strong cash flow generation
- Expect strong underlying agriculture and fertilizer industry fundamentals to continue
- North American demand for nylon and chemical intermediates mixed overall; softness in consumer durables and building and construction end markets
- Targeting our typical high plant utilization rates as supported by our global competitive position
-
Capital Expenditures tracking to approximately
for the full year 2022$95 million -
Expect pre-tax income impact of planned plant turnarounds to be
to$28 million in 2023 versus approximately$33 million in 2022$50 million
"Our outlook is supported by our diverse product portfolio, advantage of our business model, and strong underlying agriculture and fertilizer industry fundamentals. The growth prospects of
Conference Call Information
About
Forward Looking Statements
This release contains certain statements that may be deemed “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, that address activities, events or developments that our management intends, expects, projects, believes or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements may be identified by words such as "expect," "anticipate," "estimate," “outlook,” "project," "strategy," "intend," "plan," "target," "goal," "may," "will," "should" and "believe" and other variations or similar terminology and expressions. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks, uncertainties and other factors, many of which are beyond our control and difficult to predict, which may cause the actual results or performance of the Company to be materially different from any future results or performance expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: general economic and financial conditions in the
Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures intended to supplement, not to act as substitutes for, comparable GAAP measures. Reconciliations of non-GAAP financial measures to GAAP financial measures are provided in this press release. Investors are urged to consider carefully the comparable GAAP measures and the reconciliations to those measures provided. Non-GAAP measures in this press release may be calculated in a way that is not comparable to similarly-titled measures reported by other companies.
|
|||||||
|
|||||||
Condensed Consolidated Balance Sheets |
|||||||
(Unaudited) |
|||||||
(Dollars in thousands, except share and per share amounts) |
|||||||
|
|
|
|
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
24,694 |
|
|
$ |
15,100 |
|
Accounts and other receivables – net |
|
185,901 |
|
|
|
178,140 |
|
Inventories – net |
|
158,432 |
|
|
|
149,570 |
|
Taxes receivable |
|
14,930 |
|
|
|
947 |
|
Other current assets |
|
14,399 |
|
|
|
6,097 |
|
Total current assets |
|
398,356 |
|
|
|
349,854 |
|
|
|
|
|
||||
Property, plant and equipment – net |
|
803,188 |
|
|
|
767,964 |
|
Operating lease right-of-use assets |
|
124,960 |
|
|
|
136,207 |
|
|
|
56,192 |
|
|
|
17,592 |
|
Intangible assets |
|
50,004 |
|
|
|
17,980 |
|
Other assets |
|
22,833 |
|
|
|
22,402 |
|
Total assets |
$ |
1,455,533 |
|
|
$ |
1,311,999 |
|
|
|
|
|
||||
LIABILITIES |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
265,090 |
|
|
$ |
211,511 |
|
Accrued liabilities |
|
44,068 |
|
|
|
49,712 |
|
Income taxes payable |
|
24 |
|
|
|
9,723 |
|
Operating lease liabilities – short-term |
|
38,913 |
|
|
|
36,127 |
|
Deferred income and customer advances |
|
2,561 |
|
|
|
2,749 |
|
Total current liabilities |
|
350,656 |
|
|
|
309,822 |
|
|
|
|
|
||||
Deferred income taxes |
|
152,412 |
|
|
|
133,330 |
|
Operating lease liabilities – long-term |
|
86,304 |
|
|
|
100,580 |
|
Line of credit – long-term |
|
135,000 |
|
|
|
135,000 |
|
Postretirement benefit obligations |
|
6,868 |
|
|
|
18,243 |
|
Other liabilities |
|
10,016 |
|
|
|
13,834 |
|
Total liabilities |
|
741,256 |
|
|
|
710,809 |
|
|
|
|
|
||||
STOCKHOLDERS' EQUITY |
|
|
|
||||
Common stock, par value |
|
320 |
|
|
|
318 |
|
Preferred stock, par value |
|
— |
|
|
|
— |
|
|
|
(42 |
) |
|
|
(36 |
) |
Additional paid-in capital |
|
181,628 |
|
|
|
195,931 |
|
Retained earnings |
|
538,056 |
|
|
|
411,516 |
|
Accumulated other comprehensive loss |
|
(5,685 |
) |
|
|
(6,539 |
) |
Total stockholders' equity |
|
714,277 |
|
|
|
601,190 |
|
Total liabilities and stockholders' equity |
$ |
1,455,533 |
|
|
$ |
1,311,999 |
|
|
|||||||||||||
|
|||||||||||||
Condensed Consolidated Statements of Operations |
|||||||||||||
(Unaudited) |
|||||||||||||
(Dollars in thousands, except share and per share amounts) |
|||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||
Sales |
$ |
478,769 |
|
|
$ |
446,495 |
|
$ |
1,541,578 |
|
|
$ |
1,260,561 |
|
|
|
|
|
|
|
|
||||||
Costs, expenses and other: |
|
|
|
|
|
|
|
||||||
Costs of goods sold |
|
443,646 |
|
|
|
366,180 |
|
|
1,296,128 |
|
|
|
1,040,965 |
Selling, general and administrative expenses |
|
23,069 |
|
|
|
21,121 |
|
|
65,120 |
|
|
|
62,112 |
Interest expense, net |
|
686 |
|
|
|
1,174 |
|
|
2,017 |
|
|
|
4,096 |
Other non-operating (income) expense, net |
|
(1,394 |
) |
|
|
331 |
|
|
(1,825 |
) |
|
|
349 |
Total costs, expenses and other |
|
466,007 |
|
|
|
388,806 |
|
|
1,361,440 |
|
|
|
1,107,522 |
|
|
|
|
|
|
|
|
||||||
Income before taxes |
|
12,762 |
|
|
|
57,689 |
|
|
180,138 |
|
|
|
153,039 |
Income tax expense |
|
2,730 |
|
|
|
13,747 |
|
|
41,876 |
|
|
|
36,835 |
Net income |
$ |
10,032 |
|
|
$ |
43,942 |
|
$ |
138,262 |
|
|
$ |
116,204 |
|
|
|
|
|
|
|
|
||||||
Earnings per common share |
|
|
|
|
|
|
|
||||||
Basic |
$ |
0.36 |
|
|
$ |
1.56 |
|
$ |
4.92 |
|
|
$ |
4.13 |
Diluted |
$ |
0.35 |
|
|
$ |
1.51 |
|
$ |
4.74 |
|
|
$ |
4.02 |
|
|
|
|
|
|
|
|
||||||
Weighted average common shares outstanding |
|
|
|
|
|
|
|
||||||
Basic |
|
27,944,494 |
|
|
|
28,182,810 |
|
|
28,103,255 |
|
|
|
28,136,511 |
Diluted |
|
28,889,658 |
|
|
|
29,100,276 |
|
|
29,173,537 |
|
|
|
28,920,832 |
|
|||||||||||||||
Condensed Consolidated Statements of Cash Flows |
|||||||||||||||
(Unaudited) |
|||||||||||||||
(Dollars in thousands) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
||||||||
Net income |
$ |
10,032 |
|
|
$ |
43,942 |
|
|
$ |
138,262 |
|
|
$ |
116,204 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
||||||||
Depreciation and amortization |
|
17,644 |
|
|
|
16,325 |
|
|
|
51,870 |
|
|
|
49,058 |
|
Loss on disposal of assets |
|
503 |
|
|
|
409 |
|
|
|
1,303 |
|
|
|
842 |
|
Deferred income taxes |
|
6,138 |
|
|
|
3,423 |
|
|
|
8,696 |
|
|
|
11,235 |
|
Stock-based compensation |
|
2,220 |
|
|
|
2,499 |
|
|
|
7,599 |
|
|
|
8,606 |
|
Accretion of deferred financing fees |
|
155 |
|
|
|
142 |
|
|
|
464 |
|
|
|
424 |
|
Changes in assets and liabilities, net of business acquisitions: |
|
|
|
|
|
|
|
||||||||
Accounts and other receivables |
|
59,491 |
|
|
|
(5,575 |
) |
|
|
7,346 |
|
|
|
(46,549 |
) |
Inventories |
|
(2,985 |
) |
|
|
(2,807 |
) |
|
|
27 |
|
|
|
37,885 |
|
Taxes receivable |
|
(13,983 |
) |
|
|
26 |
|
|
|
(13,983 |
) |
|
|
11,952 |
|
Accounts payable |
|
(18,662 |
) |
|
|
20,226 |
|
|
|
43,468 |
|
|
|
27,047 |
|
Income taxes payable |
|
(8 |
) |
|
|
— |
|
|
|
(9,699 |
) |
|
|
— |
|
Accrued liabilities |
|
1,155 |
|
|
|
1,843 |
|
|
|
(7,666 |
) |
|
|
6,418 |
|
Deferred income and customer advances |
|
954 |
|
|
|
188 |
|
|
|
(188 |
) |
|
|
(23,241 |
) |
Other assets and liabilities |
|
(3,720 |
) |
|
|
(4,153 |
) |
|
|
(23,512 |
) |
|
|
(14,358 |
) |
Net cash provided by operating activities |
|
58,934 |
|
|
|
76,488 |
|
|
|
203,987 |
|
|
|
185,523 |
|
|
|
|
|
|
|
|
|
||||||||
Cash flows from investing activities: |
|
|
|
|
|
|
|
||||||||
Expenditures for property, plant and equipment |
|
(22,231 |
) |
|
|
(12,993 |
) |
|
|
(61,010 |
) |
|
|
(37,471 |
) |
Acquisition of business |
|
— |
|
|
|
— |
|
|
|
(97,456 |
) |
|
|
(9,523 |
) |
Other investing activities |
|
(366 |
) |
|
|
(493 |
) |
|
|
(1,587 |
) |
|
|
(975 |
) |
Net cash used for investing activities |
|
(22,597 |
) |
|
|
(13,486 |
) |
|
|
(160,053 |
) |
|
|
(47,969 |
) |
|
|
|
|
|
|
|
|
||||||||
Cash flows from financing activities: |
|
|
|
|
|
|
|
||||||||
Borrowings from line of credit |
|
123,500 |
|
|
|
29,000 |
|
|
|
354,000 |
|
|
|
133,500 |
|
Payments of line of credit |
|
(135,000 |
) |
|
|
(89,000 |
) |
|
|
(354,000 |
) |
|
|
(273,500 |
) |
Principal payments of finance leases |
|
(231 |
) |
|
|
(170 |
) |
|
|
(712 |
) |
|
|
(534 |
) |
Dividend payments |
|
(4,051 |
) |
|
|
— |
|
|
|
(11,083 |
) |
|
|
— |
|
Purchase of treasury stock |
|
(13,172 |
) |
|
|
— |
|
|
|
(23,591 |
) |
|
|
(589 |
) |
Issuance of common stock |
|
14 |
|
|
|
156 |
|
|
|
1,046 |
|
|
|
202 |
|
Net cash used for financing activities |
|
(28,940 |
) |
|
|
(60,014 |
) |
|
|
(34,340 |
) |
|
|
(140,921 |
) |
|
|
|
|
|
|
|
|
||||||||
Net change in cash and cash equivalents |
|
7,397 |
|
|
|
2,988 |
|
|
|
9,594 |
|
|
|
(3,367 |
) |
Cash and cash equivalents at beginning of period |
|
17,297 |
|
|
|
4,251 |
|
|
|
15,100 |
|
|
|
10,606 |
|
Cash and cash equivalents at the end of period |
$ |
24,694 |
|
|
$ |
7,239 |
|
|
$ |
24,694 |
|
|
$ |
7,239 |
|
|
|
|
|
|
|
|
|
||||||||
Supplemental non-cash investing activities: |
|
|
|
|
|
|
|
||||||||
Capital expenditures included in accounts payable |
|
|
|
|
$ |
19,182 |
|
|
$ |
6,783 |
|
||||
|
|||||||||||||||
|
|||||||||||||||
Non-GAAP Measures |
|||||||||||||||
(Dollars in thousands, except share and per share amounts) |
|||||||||||||||
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Net cash provided by operating activities |
$ |
58,934 |
|
|
$ |
76,488 |
|
|
$ |
203,987 |
|
|
$ |
185,523 |
|
Expenditures for property, plant and equipment |
|
(22,231 |
) |
|
|
(12,993 |
) |
|
|
(61,010 |
) |
|
|
(37,471 |
) |
Free cash flow (1) |
$ |
36,703 |
|
|
$ |
63,495 |
|
|
$ |
142,977 |
|
|
$ |
148,052 |
|
|
|
|
|
|
|
|
|
||||||||
(1) Free cash flow is a non-GAAP measure defined as Net cash provided by operating activities less Expenditures for property, plant and equipment |
The Company believes that this metric is useful to investors and management as a measure to evaluate our ability to generate cash flow from business operations and the impact that this cash flow has on our liquidity.
Reconciliation of Net Income to Adjusted EBITDA and Earnings Per Share to Adjusted Earnings Per Share |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Net income |
$ |
10,032 |
|
|
$ |
43,942 |
|
|
$ |
138,262 |
|
|
$ |
116,204 |
|
Non-cash stock-based compensation |
|
2,220 |
|
|
|
2,499 |
|
|
|
7,599 |
|
|
|
8,606 |
|
Non-recurring, unusual or extraordinary expenses |
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Non-cash amortization from acquisitions |
|
532 |
|
|
|
65 |
|
|
|
1,284 |
|
|
|
174 |
|
One-time M&A costs |
|
— |
|
|
|
— |
|
|
|
277 |
|
|
|
172 |
|
Benefit from income taxes relating to reconciling items |
|
(466 |
) |
|
|
(391 |
) |
|
|
(1,461 |
) |
|
|
(1,378 |
) |
Adjusted Net Income |
|
12,318 |
|
|
|
46,115 |
|
|
|
145,961 |
|
|
|
123,778 |
|
Interest expense, net |
|
686 |
|
|
|
1,174 |
|
|
|
2,017 |
|
|
|
4,096 |
|
Income tax expense - adjusted |
|
3,196 |
|
|
|
14,138 |
|
|
|
43,337 |
|
|
|
38,213 |
|
Depreciation and amortization - adjusted |
|
17,113 |
|
|
|
16,260 |
|
|
|
50,586 |
|
|
|
48,884 |
|
Adjusted EBITDA |
$ |
33,313 |
|
|
$ |
77,687 |
|
|
$ |
241,901 |
|
|
$ |
214,971 |
|
|
|
|
|
|
|
|
|
||||||||
Sales |
$ |
478,769 |
|
|
$ |
446,495 |
|
|
$ |
1,541,578 |
|
|
$ |
1,260,561 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted EBITDA Margin (2) |
|
7.0 |
% |
|
|
17.4 |
% |
|
|
15.7 |
% |
|
|
17.1 |
% |
|
|
|
|
|
|
|
|
||||||||
(2) Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales |
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||
Net Income |
$ |
10,032 |
|
$ |
43,942 |
|
$ |
138,262 |
|
$ |
116,204 |
Adjusted Net Income |
|
12,318 |
|
|
46,115 |
|
|
145,961 |
|
|
123,778 |
|
|
|
|
|
|
|
|
||||
Weighted-average number of common shares outstanding - basic |
|
27,944,494 |
|
|
28,182,810 |
|
|
28,103,255 |
|
|
28,136,511 |
Dilutive effect of equity awards and other stock-based holdings |
|
945,164 |
|
|
917,466 |
|
|
1,070,282 |
|
|
784,321 |
Weighted-average number of common shares outstanding - diluted |
|
28,889,658 |
|
|
29,100,276 |
|
|
29,173,537 |
|
|
28,920,832 |
|
|
|
|
|
|
|
|
||||
EPS - Basic |
$ |
0.36 |
|
$ |
1.56 |
|
$ |
4.92 |
|
$ |
4.13 |
EPS - Diluted |
$ |
0.35 |
|
$ |
1.51 |
|
$ |
4.74 |
|
$ |
4.02 |
Adjusted EPS - Basic |
$ |
0.44 |
|
$ |
1.64 |
|
$ |
5.19 |
|
$ |
4.40 |
Adjusted EPS - Diluted |
$ |
0.43 |
|
$ |
1.58 |
|
$ |
5.00 |
|
$ |
4.28 |
The Company believes the non-GAAP financial measures presented in this release provide meaningful supplemental information as they are used by the Company’s management to evaluate the Company’s operating performance, enhance a reader’s understanding of the financial performance of the Company, and facilitate a better comparison among fiscal periods and performance relative to its competitors, as these non-GAAP measures exclude items that are not considered core to the Company’s operations.
|
|||||
|
|||||
Appendix |
|||||
(Pre-tax income impact, Dollars in millions) |
|||||
Planned Plant Turnaround Schedule (3) |
|||||
|
1Q |
2Q |
3Q |
4Q |
FY |
2017 |
— |
|
|
|
|
2018 |
|
|
|
— |
|
2019 |
— |
|
|
|
|
2020 |
|
|
|
|
|
2021 |
|
|
— |
|
|
2022 |
|
|
|
— |
|
2023E |
|
— |
|
— |
|
(3) Primarily reflects the impact of fixed cost absorption, maintenance expense, and the purchase of feedstocks which are normally manufactured by the Company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221103006335/en/
Media
(973) 526-1615
janeen.lawlor@advansix.com
Investors
(973) 526-1700
adam.kressel@advansix.com
Source:
FAQ
What were AdvanSix's sales for Q3 2022?
How did AdvanSix's earnings per share change in Q3 2022?
What factors impacted AdvanSix's financial performance in Q3 2022?
What is the outlook for AdvanSix in Q4 2022?